Mersen : Back on a long term support level
Entry price | Target | Stop-loss | Potential |
---|
€35.05 |
€39 |
€33.45 |
+11.27% |
---|
Mersen shares have returned to important technical levels around 35.22 EUR based on weekly price data. The timing seems attractive to be a buyer of this stock.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● In a short-term perspective, the company has interesting fundamentals.
Strengths● The share is getting closer to its long-term support in weekly data, at EUR 35.22, which offers good timing for buyers.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 35.22 EUR
Weaknesses● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The group usually releases earnings worse than estimated.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.